Topiramate
Topiramate is an anticonvulsant medication used to treat seizures and prevent migraine headaches.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 172 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
⭐ Key facts about Topiramate
1 INDICATIONS AND USAGE Topiramate extended-release capsules are indicated for: Epilepsy: initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 6 years of age and older ( 1.1) ; adjunctive therapy for the treatment of partial-onset, primary g…
Read the full label section on DailyMed →2 DOSAGE AND ADMINISTRATION Topiramate extended-release capsules initial dose, titration, and recommended maintenance dose varies by indication and age group.
Read the full label section on DailyMed →6 ADVERSE REACTIONS The following serious adverse reactions are discussed in more detail in other sections of the labeling: Acute Myopia and Secondary Angle Closure Glaucoma [see Warnings and Precautions (5.1 )] Visual Field Defects [see Warnings and Precautions ( 5.2 )] Oligohydrosis and Hypertherm…
Read the full label section on DailyMed →5 WARNINGS AND PRECAUTIONS Acute myopia and secondary angle closure glaucoma: can lead to permanent visual loss; discontinue topiramate extended-release capsules as soon as possible ( 5.1 ) Visual field defects: consider discontinuation of topiramate extended-release capsules ( 5.2 ) Oligohydrosis a…
Read the full label section on DailyMed →stored in a tightly closed container at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) . Protect from moisture.
Drawn from the manufacturer’s FDA-filed label. Read the official label on DailyMed →
📖 Topiramate: Patient Information Guide
A plain-language walkthrough of Topiramate — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What It Treats▾
Topiramate is used alone or with other medications to treat certain types of seizures including primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) and partial onset seizures (seizures that involve only one part of the brain). Topiramate is also used with other medications to control seizures in people who have Lennox-Gastaut syndrome (a disorder that causes seizures and developmental delays). Topiramate is also used to prevent migraine headaches but not to relieve the pain of migraine headaches when they occur. Topiramate is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.
💊How to Take It▾
Topiramate comes as a tablet, a sprinkle capsule (capsule that contains small beads of medication that can be sprinkled on food), an extended-release (long-acting) capsule and solution (liquid) to take by mouth. The tablets, sprinkle capsules, and solution are usually taken with or without food once or twice a day. The extended-release capsules are usually taken with or without food once a day. Take topiramate at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take topiramate exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
Be sure that the prescription your doctor gives you is clear and easy to read. Talk to your pharmacist to be sure that you are given topiramate. If you think you were given the wrong medication, talk to your pharmacist. Do not take any medication unless you are certain it is the medication that your doctor prescribed.
Topiramate tablets have a bitter taste so you should swallow them whole. It is especially important that you not take topiramate tablets that have been broken for any length of time because tablets that are broken may lose their effectiveness over time.
Swallow extended-release capsules (Trokendi XR brand only) whole; do not split, chew, or sprinkle on food.
The sprinkle and extended-release capsules (Qudexy XR brand only) may be swallowed whole or opened and poured over soft food. To take the sprinkle capsules or extended-release capsules (Qudexy XR brand only) mixed with food, you can carefully open the capsule and sprinkle the entire contents onto a spoonful of soft foods, such as applesauce. Swallow the mixture right after you mix it without chewing, and then drink fluids to make sure that you swallow all of the medication.
Use a marked (calibrated) measuring device to measure the topiramate solution dose to make sure the correct dose is being given. Do not use a household teaspoon or tablespoon. Ask your pharmacist for an measuring device if one is not included with your medication.
Your doctor will probably start you on a low dose of topiramate and gradually increase your dose, not more than once every week.
Topiramate may control your seizures or migraines but will not cure your condition. Continue to take topiramate even if you feel well. Do not stop taking topiramate without talking to your doctor, even if you experience side effects such as unusual changes in behavior or mood. If you suddenly stop taking topiramate, you may have severe seizures, even if you have not had seizures in the past. Your doctor will probably decrease your dose gradually.
Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with topiramate and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) or the manufacturer's website to obtain the Medication Guide.
⏰If You Miss a Dose▾
If you are taking topiramate tablets, sprinkle capsules, or solution, take the missed dose as soon as you remember it. However, if it is less than 6 hours before you are scheduled to take your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
If you are taking topiramate extended-release capsules, take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one. If you have missed more than one dose, contact your doctor.
🍽️Food, Alcohol & Dietary Advice▾
Talk to your doctor before changing your diet or beginning any type of weight loss program. Do not follow a ketogenic diet (a high-fat, low-carbohydrate diet used to control seizures) or any other high-fat, low-carbohydrate diet while you are taking this medication.
⚠️Warnings & Precautions▾
Before taking topiramate,
-
tell your doctor and pharmacist if you are allergic to topiramate, any other medications, or any of the ingredients in topiramate tablets, sprinkle capsules, extended-release capsules, and solution. Ask your pharmacist for a list of the ingredients.
-
tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
-
tell your doctor what nonprescription or herbal products you are taking, especially aspirin and other nonsteroidal anti-inflammatory medications (NSAIDs) such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn). Be sure to let your doctor and pharmacist know that you are taking these medications before you start taking topiramate. Do not start any of these medications while taking topiramate without discussing with your healthcare provider.
-
tell your doctor if you or any family members have or have ever had kidney stones, and if you have ever thought about killing yourself or tried to do so. Also tell your doctor if you have or have ever had metabolic acidosis (a disturbance in the body's acid-base balance that results in excessive acidity of the blood); osteopenia, osteomalacia, or osteoporosis (conditions in which the bones are soft or brittle and may break easily); glaucoma (a type of eye disease); any disease that affects your breathing such as asthma or chronic obstructive pulmonary disease (COPD); depression or abnormal moods; a growth problem; or liver or kidney disease. Also tell your doctor if you have diarrhea or if you develop diarrhea during your treatment.
-
tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you are pregnant or plan to become pregnant, your doctor may prescribe a different medication instead of topiramate because topiramate may harm the fetus. If you do not plan to become pregnant, you should use birth control to prevent pregnancy during your treatment with topiramate. Talk to your doctor about what type of birth control you should use, because taking topiramate may decrease the effectiveness of some types of birth control. If you become pregnant while you are taking topiramate, call your doctor right away, but do not stop taking topiramate before talking to your doctor.
-
if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking topiramate.
-
you should know that topiramate may make you drowsy, dizzy, confused, or unable to concentrate. Do not drive a car or operate machinery until you know how this medication affects you.
-
if you are taking topiramate to control seizures, you should know that you may continue to have seizures during your treatment. You may need to avoid activities such as swimming, driving, and climbing so that you will not harm yourself or others if you lose consciousness during a seizure.
-
tell your doctor if you if you drink alcohol. You should not drink alcohol within 6 hours before and 6 hours after you take extended-release capsules (Trokendi XR brand only). Your doctor may tell you not to drink alcohol while taking topiramate.
-
you should know that topiramate can prevent you from sweating and make it harder for your body to cool down when it gets very hot. This happens most often in warm weather and to children who take topiramate. Avoid exposure to heat, drink plenty of fluids and tell your doctor if you have a fever, headache, muscle cramps, or an upset stomach, or if you are not sweating as usual.
-
you should know that you may be more likely to develop a kidney stone while you are taking topiramate. Drink plenty of water or other fluids every day to prevent kidney stones from forming.
-
you should know that your mental health may change in unexpected ways and you may become suicidal (thinking about harming or killing yourself or planning or trying to do so) while you are taking topiramate for the treatment of epilepsy, mental illness, or other conditions. A small number of adults and children 5 years of age and older (about 1 in 500 people) who took anticonvulsants such as topiramate to treat various conditions during clinical studies became suicidal during their treatment. Some of these people developed suicidal thoughts and behavior as early as 1 week after they started taking the medication. There is a risk that you may experience changes in your mental health if you take an anticonvulsant medication such as topiramate, but there may also be a risk that you will experience changes in your mental health if your condition is not treated. You and your doctor will decide whether the risks of taking an anticonvulsant medication are greater than the risks of not taking the medication. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: panic attacks; agitation or restlessness; new or worsening irritability, anxiety, or depression; acting on dangerous impulses; difficulty falling or staying asleep; aggressive, angry, or violent behavior; mania (frenzied, abnormally excited mood); talking or thinking about wanting to hurt yourself or end your life; withdrawing from friends and family; preoccupation with death and dying; giving away prized possessions; or any other unusual changes in behavior or mood. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor if you are unable to seek treatment on your own.
🤒Side Effects in Detail▾
-
Topiramate may cause other side effects. Tell your doctor if any of these symptoms are severe or do not go away:
-
numbness, burning, or tingling in the hands or feet
-
slowed reactions
-
nervousness
-
headache
-
drowsiness
-
weakness
-
uncontrollable shaking of a part of the body
-
uncontrollable eye movements
-
weight loss
-
constipation
-
nausea
-
stomach pain
-
change in ability to taste food
-
dry mouth
-
nosebleed
-
back, muscle, leg, or bone pain
-
missed menstrual periods
-
excessive menstrual bleeding
-
-
Some side effects can be serious. If you experience any of the following symptoms or those listed in the SPECIAL PRECAUTIONS section, call your doctor immediately:
-
rash, skin blisters, or skin peeling
-
blurred vision
-
loss of vision
-
double vision
-
eye pain
-
eye redness
-
worsening of seizures
-
feeling cold, chills, or low body temperature
-
difficulty concentrating
-
speech problems, especially difficulty thinking of specific words
-
confusion
-
memory problems
-
coma (loss of consciousness for a period of time)
-
loss of coordination
-
pounding or irregular heartbeat
-
chest pain
-
shortness of breath or trouble breathing
-
fast, shallow breathing
-
inability to respond to things around you
-
excessive tiredness
-
diarrhea
-
vomiting
-
loss of appetite
-
intense back or side pain
-
bloody, cloudy, or foul-smelling urine
-
constant need to urinate
-
difficulty urinating or pain when urinating
-
fever or other signs of infection
-
unusual bleeding or bruising
-
-
Topiramate may cause osteoporosis (a condition in which bones can break more easily) in adults and rickets (abnormal, curved bone growth) in children. Topiramate may also slow the growth of children and may decrease the final height that children reach. Talk to your doctor about the risks of taking topiramate.
-
Topiramate may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
-
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).
🚑If You Take Too Much▾
In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.
Symptoms of overdose may include the following:
-
seizures
-
drowsiness
-
speech problems
-
blurred vision
-
double vision
-
trouble thinking
-
tiredness
-
loss of coordination
-
loss of consciousness
-
dizziness
-
stomach pain
-
vomiting
-
agitation
-
depression
-
loss of appetite
-
pounding or irregular heartbeat
-
fast, shallow breathing
📦Storage & Disposal▾
Keep this medication in the container it came in, tightly closed, and out of reach of children. Tablets, extended-release capsules and solution should be stored at room temperature and away from excess heat and moisture (not in the bathroom). Sprinkle capsules should be stored at or below 77°F (25°C) and not in the bathroom. Never store mixtures of topiramate sprinkles and soft food. These should be used right away or discarded. Dispose of any unused solution 30 days after first opening the bottle.
It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.
➕Other Uses▾
Topiramate is also used for the management of alcohol dependence. Talk to your doctor about the risks of using this medication for your condition.
This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.
ℹ️Good to Know▾
Keep all appointments with your doctor and the laboratory. Your doctor will order certain lab tests to check your body's response to topiramate.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
📄 Written from Topiramate’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
Supplements & herbs that interact with Topiramate
125 supplements and herbal products have documented interactions with Topiramate in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.
- Major · 7
- Moderate · 101
- Minor · 17
Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrient depletion considerations
Topiramate has been associated with lower levels of 1 nutrient in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.
❓ Topiramate: frequently asked questions
Common questions about Topiramate, answered from its official FDA-filed labeling.
What is Topiramate used for? ▾
How is Topiramate taken? ▾
What are the side effects of Topiramate? ▾
What should I know before taking Topiramate? ▾
Can I take Topiramate while pregnant? ▾
How should I store Topiramate? ▾
Is Topiramate available over the counter? ▾
When was Topiramate first available? ▾
Who makes Topiramate? ▾
💬 Answers drafted from Topiramate’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Topiramate comes
Topiramate is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Tablet
Extended-release capsule
Capsule
Oral solution
Other oral form
📊 Topiramate across the U.S. market
How Topiramate appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (32) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Topiramate is used
A general measure of how commonly Topiramate is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Topiramate is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Topiramate prescribed? Of the 1,596 medications we measure, Topiramate ranks #83 by Medicaid prescriptions — more than 95% of them.
Utilization by Topiramate product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
topiramate 50 MG Oral Tablet Most dispensed
Summed across the 20 of 239 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 151226
topiramate 25 MG Oral Tablet
Summed across the 21 of 228 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 199888
topiramate 100 MG Oral Tablet
Summed across the 20 of 214 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 199889
topiramate 200 MG Oral Tablet
Summed across the 15 of 110 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 199890
topiramate 25 MG Oral Capsule
Summed across the 6 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 205315
topiramate 25 MG/ML Oral Solution
Summed across the 6 of 12 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 2586427
24 HR topiramate 100 MG Extended Release Oral Capsule
Summed across the 4 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1437283
24 HR topiramate 200 MG Extended Release Oral Capsule
Summed across the 5 of 28 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1437288
topiramate 15 MG Oral Capsule
Summed across the 5 of 29 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 205316
24 HR topiramate 50 MG Extended Release Oral Capsule
Summed across the 4 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1436239
Sprinkle 24 HR topiramate 100 MG Extended Release Oral Capsule
Summed across the 5 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1812427
Sprinkle 24 HR topiramate 200 MG Extended Release Oral Capsule
Summed across the 6 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1812419
24 HR topiramate 25 MG Extended Release Oral Capsule
Summed across the 4 of 30 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1437278
Sprinkle 24 HR topiramate 150 MG Extended Release Oral Capsule
Summed across the 4 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1494769
Sprinkle 24 HR topiramate 50 MG Extended Release Oral Capsule
Summed across the 4 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1812425
Sprinkle 24 HR topiramate 25 MG Extended Release Oral Capsule
Summed across the 4 of 15 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 1812421
topiramate 50 MG Oral Capsule
Summed across the 2 of 7 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 252413
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Topiramate, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 135 of 1,062 listed Topiramate NDCs with Medicaid activity.
🔍 Compare Topiramate products
A representative set of FDA-listed product records for Topiramate — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 15 mg | Oral | Advagen Pharma Ltd | ANDA | View NDC → |
| 25 mg | Oral | Advagen Pharma Ltd | ANDA | View NDC → |
| 50 mg | Oral | Advagen Pharma Ltd | ANDA | View NDC → |
| 15 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 25 mg | Oral | Ascend Laboratories, LLC | ANDA | View NDC → |
| 15 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 15 mg | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 25 mg | Oral | Glenmark Pharmaceuticals Inc., USA | ANDA | View NDC → |
| 15 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Golden State Medical Supply, Inc. × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | ANDA | View NDC → |
| 15 mg | Oral | Janssen Pharmaceuticals, Inc. × 3 listings | NDA | View NDC → |
| 25 mg | Oral | Janssen Pharmaceuticals, Inc. × 3 listings | NDA | View NDC → |
| 25 mg | Oral | Remedyrepack Inc. × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Teva Pharmaceuticals USA, Inc. × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Teva Pharmaceuticals USA, Inc. × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | TWi Pharmaceuticals, Inc. | ANDA | View NDC → |
| 25 mg | Oral | TWi Pharmaceuticals, Inc. | ANDA | View NDC → |
| 15 mg | Oral | Upsher-Smith Laboratories, LLC × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Upsher-Smith Laboratories, LLC × 2 listings | ANDA | View NDC → |
| 15 mg | Oral | Zydus Lifesciences Limited × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Zydus Lifesciences Limited × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Zydus Lifesciences Limited | ANDA | View NDC → |
| 15 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 25 mg | Oral | Zydus Pharmaceuticals (USA) Inc. | ANDA | View NDC → |
| 15 mg | Oral | Zydus Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Zydus Pharmaceuticals USA Inc. × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | Zydus Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 💊Extended-release capsule | ||||
| 25 mg | Oral | Ajanta Pharma USA Inc. × 5 listings | ANDA | View NDC → |
| 50 mg | Oral | Ajanta Pharma USA Inc. × 5 listings | ANDA | View NDC → |
| 100 mg | Oral | Ajanta Pharma USA Inc. × 5 listings | ANDA | View NDC → |
| 150 mg | Oral | Ajanta Pharma USA Inc. × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | Ajanta Pharma USA Inc. × 5 listings | ANDA | View NDC → |
| 25 mg | Oral | AvKARE | ANDA | View NDC → |
| 50 mg | Oral | AvKARE | ANDA | View NDC → |
| 100 mg | Oral | AvKARE | ANDA | View NDC → |
| 200 mg | Oral | AvKARE | ANDA | View NDC → |
| 25 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 50 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 200 mg | Oral | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 25 mg | — | Catalent Pharma Solutions, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 50 mg | — | Catalent Pharma Solutions, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 100 mg | — | Catalent Pharma Solutions, LLC × 2 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 150 mg | — | Catalent Pharma Solutions, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 200 mg | — | Catalent Pharma Solutions, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 25 mg | — | Catalent Pharma Solutions LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 50 mg | — | Catalent Pharma Solutions LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 100 mg | — | Catalent Pharma Solutions LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 200 mg | — | Catalent Pharma Solutions LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
| 25 mg | Oral | Dr. Reddys Laboratories Inc. | ANDA | View NDC → |
| 50 mg | Oral | Dr. Reddys Laboratories Inc. | ANDA | View NDC → |
| 100 mg | Oral | Dr. Reddys Laboratories Inc. | ANDA | View NDC → |
| 200 mg | Oral | Dr. Reddys Laboratories Inc. | ANDA | View NDC → |
| 25 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 50 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 200 mg | Oral | Endo USA, Inc. | ANDA | View NDC → |
| 25 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 50 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 100 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 150 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 200 mg | Oral | Glenmark Pharmaceuticals Inc., USA × 3 listings | ANDA | View NDC → |
| 25 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 50 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 200 mg | Oral | Lupin Pharmaceuticals, Inc. | ANDA | View NDC → |
| 25 mg | Oral | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| 50 mg | Oral | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| 100 mg | Oral | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| 150 mg | Oral | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| 200 mg | Oral | NorthStar RxLLC × 2 listings | ANDA | View NDC → |
| 25 mg | Oral | Par Health USA, LLC | ANDA | View NDC → |
| 50 mg | Oral | Par Health USA, LLC | ANDA | View NDC → |
| 100 mg | Oral | Par Health USA, LLC | ANDA | View NDC → |
| 200 mg | Oral | Par Health USA, LLC | ANDA | View NDC → |
| 25 mg | Oral | Par Pharmaceutical, Inc. | ANDA | View NDC → |
| 50 mg | Oral | Par Pharmaceutical, Inc. | ANDA | View NDC → |
| 100 mg | Oral | Par Pharmaceutical, Inc. | ANDA | View NDC → |
| 200 mg | Oral | Par Pharmaceutical, Inc. | ANDA | View NDC → |
| 25 mg | Oral | Supernus Pharmaceuticals × 2 listings | NDA | View NDC → |
| 50 mg | Oral | Supernus Pharmaceuticals × 2 listings | NDA | View NDC → |
| 100 mg | Oral | Supernus Pharmaceuticals × 2 listings | NDA | View NDC → |
| 200 mg | Oral | Supernus Pharmaceuticals × 2 listings | NDA | View NDC → |
| 25 mg | Oral | Supernus Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 50 mg | Oral | Supernus Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 100 mg | Oral | Supernus Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 200 mg | Oral | Supernus Pharmaceuticals, Inc. × 2 listings | NDA | View NDC → |
| 25 mg | — | Teva Pharmaceuticals, Inc. × 2 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 25 mg | Oral | Teva Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 50 mg | Oral | Teva Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 50 mg | — | Teva Pharmaceuticals, Inc. × 2 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 100 mg | Oral | Teva Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 100 mg | — | Teva Pharmaceuticals, Inc. × 2 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 200 mg | — | Teva Pharmaceuticals, Inc. × 2 listings | DRUG FOR FURTHER PROCESSING | View NDC → |
| 200 mg | Oral | Teva Pharmaceuticals, Inc. × 3 listings | ANDA | View NDC → |
| 25 mg | Oral | Upsher-Smith Laboratories, LLC × 4 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 25 mg | Oral | Upsher-Smith Laboratories, LLC × 4 listings | NDA | View NDC → |
| 50 mg | Oral | Upsher-Smith Laboratories, LLC × 4 listings | NDA | View NDC → |
| 50 mg | Oral | Upsher-Smith Laboratories, LLC × 4 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 100 mg | Oral | Upsher-Smith Laboratories, LLC × 3 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 100 mg | Oral | Upsher-Smith Laboratories, LLC × 4 listings | NDA | View NDC → |
| 150 mg | Oral | Upsher-Smith Laboratories, LLC × 2 listings | NDA | View NDC → |
| 150 mg | Oral | Upsher-Smith Laboratories, LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 200 mg | Oral | Upsher-Smith Laboratories, LLC × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 200 mg | Oral | Upsher-Smith Laboratories, LLC × 2 listings | NDA | View NDC → |
| 💊Other oral form | ||||
| 1 kg/kg | — | Catalent Pharma Solutions, LLC | DRUG FOR FURTHER PROCESSING | View NDC → |
Showing 200 of 808 products — FDA National Drug Code Directory. See every product, package size and price: browse all 808 Topiramate NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Topiramate — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Topiramate in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Topiramate went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 38404 4 dose forms · 17 strengths
-
Dose form (SCDF) Extended Release Oral Capsule RxCUI 1436238In current FDA listingsClinical drug / strength (SCD) Sprinkle 24 HR topiramate 100 MGRxCUI 1812427Sprinkle 24 HR topiramate 150 MGRxCUI 1494769Sprinkle 24 HR topiramate 200 MGRxCUI 1812419Sprinkle 24 HR topiramate 25 MGRxCUI 1812421Sprinkle 24 HR topiramate 50 MGRxCUI 181242524 HR topiramate 100 MGRxCUI 143728324 HR topiramate 200 MGRxCUI 143728824 HR topiramate 25 MGRxCUI 143727824 HR topiramate 50 MGRxCUI 1436239 -
Dose form (SCDF) Oral Capsule RxCUI 374165In current FDA listings -
Dose form (SCDF) Oral Solution RxCUI 2586426In current FDA listingsClinical drug / strength (SCD) 25 MG/MLRxCUI 2586427 -
Dose form (SCDF) Oral Tablet RxCUI 374166In current FDA listings
Look up RxCUI 38404 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Topiramate is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
…and 16 more on the FDA NDC directory.
RxNorm drug class
Topiramate belongs to the Centrally acting antiobesity products class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 172 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Upsher-Smith Laboratories, LLC is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.